Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar thunderhawke23 (< 20) Submitted: 3/30/2011 10:17:51 AM : Outperform Start Price: $48.84 VRX Score: -0.44

strong CEO

Featured Broker Partners


Advertisement